
Organometallics p. 1051 - 1057 (1987)
Update date:2022-08-11
Topics:
Goh, Lai Yoong
Hambley, Trevor W.
Robertson, Glen B.
The instantaneous reaction of [CpCr(CO)3]2 (Cp = η5-C5H5) in tetrahydrofuran or toluene with stoichiometric amounts of elemental sulfur produced Cp2Cr2(CO)4S (1) and Cp2Cr2(CO)5S2 (2) in near quantitative yields. A solution of 2 on standing 1 h at ambient temperature gave a mixture of Cp2Cr2(CO)4S2 (3) (76%) and 1. The transformation of the very labile complex 2 to 3 with the cleavage of a CO ligand thence to the linear multiple bonded Cr-S-Cr complex 1 with extrusion of a S atom and finally to Cp4Cr4S4 was demonstrated by a time-dependent NMR study at 30°C. When 2 was treated with CF3SO3CH3, one of the S atoms was immediately methylated, giving [Cp2Cr2(CO)5S2(CH 3)](SO3CF3) (4) as a fine black unstable solid, which decomposed in solution to give 1 and [Cp4Cr4S4(CH3)](SO 3CF3) (5). Complexes 1-3 have been characterized by elemental, spectral, and crystal structure analyses. The structure of 1 has been reported previously. Crystals of 2 are monoclinic, P21/n, with a = 11.638 (4) A?, b = 15.508 (5) A?, c = 9.825 (3) A?, β = 111.56 (2)°, and Z = 4. Crystals of 3 are monoclinic, P21/c, with a = 8.214 (1) A?, b = 11.464 (2) A?, c = 16.182 (3) A?, β = 92.44 (1)°, and Z = 4. The disulfur ligand bridges the two chromium centers asymmetrically μ-η1,η2 in 2 and symmetrically μ-η2 in 3. S-S distances [2.010 (4) A?, 2; 1.990 (1) A?, 3] are similar to those found in other transition-metal μ-S2 complexes. Metal atoms in both complexes exhibit 4:3, 7-coordination.
Contact:+86-021-6989-5597
Address:No.80 Yichuan Rd., Putuo District,Shanghai,P.R.China
Contact:86+21-56421993
Address:3F,BUILDING 10,NO.2889 JINKE ROAD, SHANGHAI.
NEW FORTUNE INDUSTRIAL CO.,LTD.
website:http://newfortune.lookchem.com/
Contact:+86-25-8645-9456
Address:C4-105 GREEN ISLAND FLOWER TOWN
Contact:+86+21-58956006 15800617331
Address:402 Room, 150# Cailun Road, Zhangjiang high tech park, Shanghai
Chengdu Aslee Biopharmaceuticals, Inc
Contact:18608018419
Address:Chengdu Aslee Biopharmaceuticals, Inc
Doi:10.1016/S0040-4039(00)95231-6
(1989)Doi:10.1016/j.ijbiomac.2017.11.138
(2018)Doi:10.1021/jacs.7b12928
(2018)Doi:10.1080/00397919708003372
(1997)Doi:10.1080/17415993.2014.950661
(2014)Doi:10.1080/10587250008025236
(2000)